×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
PDS Biotech appoints Stephan Toutain as COO By Investing.com
Investing.com
PRINCETON, N.J. - PDS Biotechnology (NASDAQ:PDSB) Corporation (NASDAQ:PDSB), a late-stage immunotherapy company, announced the appointment...
5 days ago
PDS Biotech names Stephan Toutain as COO
The Pharma Letter
New Jersey, USA-based PDS Biotechnology (Nasdaq: PDSB) today announced the appointment of Stephan Toutain, as chief operating officer (COO),...
6 days ago
Instead of credible data, PDS Biotech delivers 'results might get better, later' promises
STAT
The company's drug, called PDS0101, is designed to recruit T cells to attack tumors caused by the human papilloma virus, or HPV.
10 months ago
All You Need to Know About PDS Biotechnology (PDSB) Rating Upgrade to Buy
Yahoo Finance
PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects.
4 months ago
PDS Biotech to pursue pivotal trial in HNSCC after exciting Phase II results
Pharmaceutical Technology
PDS Biotech to pursue pivotal trial in HNSCC after exciting Phase II results. PDS0101 is a liposomal multi-peptide vaccine against HPV-16, and...
5 months ago
PDS Biotechnology: Advancement Of PDS0101 Continues With Expansion Data (NASDAQ:PDSB)
Seeking Alpha
Summary · Preliminary efficacy results from phase 1/2 Mayo Clinic study, using PDS0101 + KEYTRUDA to treat patients with Oropharyngeal cancer,...
3 months ago
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
citybiz
PRINCETON, N.J., May 02, 2024 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a late-stage immunotherapy company focused on...
6 days ago
PDS Biotech defended on Wall Street after selloff
MSN
Following a ~31% decline in the previous session, the shares of PDS Biotechnology (NASDAQ:PDSB) rose ~9% in the pre-market Tuesday as Cantor Fitzgerald and...
6 days ago
PDS Biotech appoints Lars Boesgaard as chief financial officer
ROI-NJ
PDS Biotech appoints Lars Boesgaard as chief financial officer ... PDS Biotechnology Corp., a Princeton-based firm developing a pipeline of...
5 months ago
PDS Biotech's cancer vaccine hits the mark in Phase II trial
Clinical Trials Arena
PDS Biotechnology Corp · View all · PDS0101 is a liposomal-based therapeutic vaccine intended to help the immune system respond to HPV16-...
10 months ago